The 20 Best Catecholaminergic Polymorphic Ventricular Tachycardia Doctors near Baltimore, MD

Joseph Marine, MD, MBA, FACC, FHRS, is a clinical cardiac electrophysiologist who practices primarily at the Johns Hopkins Hospital in Baltimore, Maryland. He is a Professor of Medicine at the Johns Hopkins University School of Medicine and holds appointments as Vice-Director of Operations for the Division of Cardiology and Section Chief of Cardiology for Johns Hopkins Community Physicians. He trained at UC San Francisco Medical School, Brigham and Women’s Hospital/Harvard Medical School, Boston University Medical Center, and Beth Israel Deaconess Medical Center. Dr. Marine has lectured widely on a variety of arrhythmia topics and has served as a co-director of the American College of Cardiology (ACC) Cardiovascular Overview and Board Review Course for 10 years. He currently serves on the ACC Board of Governors and is co-editor of the ACC/HRS EP Self-Assessment Program. He also serves on other committees for the ACC, the Heart Rhythm Society, and MedChi. He is co-author of more than 130 original research and review articles and has served on writing committees for several national cardiology practice and training guidelines. As a clinical cardiac electrophysiologist, Dr. Marine specializes in the diagnosis and treatment of arrhythmias, which are heart rhythm disorders that cause the heart to beat too rapidly, too slowly, or irregularly. His research focuses on further improving the safety and effectiveness of catheter ablation and other treatments for atrial fibrillation and other atrial and ventricular arrhythmias. Dr. Marine is rated as an Advanced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Atrial Fibrillation, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Arrhythmias, Cardiac Ablation, and Heart Transplant.

Edward K. Kasper, M.D. is a graduate of the Johns Hopkins University with a B.A. in Natural Sciences. He earned his M.D. at the University of Connecticut School of Medicine in 1984. His internship and residency in Internal Medicine, as well as his fellowship in Cardiovascular Medicine, were completed at the Johns Hopkins Hospital, where he then joined the faculty in 1993. He is a fellow of the American Heart Association as well as a fellow of the American College of Cardiology, having served on its board of governors from 2002 to 2006. Dr. Kasper has authored more than 100 articles and three books including, Living Well with Heart Failure. He is currently the Director of Outpatient Cardiology. Dr. Kasper's current research interests focus on the biological origins of heart failure. Specifically, his research has focused on causes and prognosis of patients with cardiomyopathy, a serious condition in which the heart has difficulty pumping blood throughout the body. Dr. Kasper works closely with his team at the Johns Hopkins Heart and Vascular Institute to understand the best ways to predict and prevent catastrophic cardiac events. With your support, Dr. Kasper will be able to continue his significant work in cardiovascular medicine in hopes of impacting the future of patients with cardiomyopathy and heart failure. Dr. Kasper is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Sengers Syndrome, Hypertrophic Cardiomyopathy (HCM), and Heart Transplant.

Degrees: BS: Massachusetts Institute of Technology 1981 Electrical Engineering MS: Massachusetts Institute of Technology 1983 Electrical Engineering PhD: Massachusetts Institute of Technology 1987 Electrical Engineering MD: Harvard 1987 Medicine Professional Appointments: 1987-1988 Intern in Medicine, Brigham and Women's Hospital 1988-1990 Resident in Medicine, Brigham and Women's Hospital 1988-1990 Research Scientist, Harvard M.I.T. Division of H.S.T. 1990-1993 Fellow in Cardiology, Johns Hopkins University 1993-1998 Assistant Professor of Medicine, Johns Hopkins University 1996- Co-Director of Cardiac Electrophysiology, Johns Hopkins Hospital 1998-2005 Associate Professor of Medicine, Johns Hopkins University 2002-2005 Associate Professor of Biomedical Engineering, Johns Hopkins University 2005- Professor of Medicine, Johns Hopkins University 2005- Professor of Biomedical Engineering, Johns Hopkins University. Dr. Berger is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Ventricular Tachycardia, Cardiac Ablation, and Pacemaker Implantation.

Charles Love is director of the Johns Hopkins Cardiac Rhythm Device Service. Dr. Love is one of the foremost international authorities on pacemaker and implantable cardioverter defibrillator implantation and management. He manages patients with all types of heart rhythm disorders and has particular interest in lead extraction and lead management strategies, with an emphasis on new tools to reduce complications and strategies to reduce infection. Dr. Love is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Arrhythmias, Sick Sinus Syndrome, Ventricular Tachycardia, Pacemaker Implantation, and Cardiac Ablation.

Dr. Chiadi Ndumele is the Director of Obesity and Cardiometabolic Research, Director of the Heart Failure Prevention Program and Associate Professor of Medicine and Epidemiology in the Division of Cardiology at Johns Hopkins University. Dr. Ndumele is a preventive cardiologist with doctorate level training in epidemiology, who leads a research program related to characterizing the relationship of obesity and cardiometabolic risk factors with the development of cardiovascular disease, with a particular focus on heart failure risk, and to refining strategies for cardiovascular disease prevention. His work additionally addresses the impact of social determinants of health on cardiometabolic risk factors and downstream cardiovascular outcomes. Dr. Ndumele received his M.D. from Harvard University and his Internal Medicine training at Brigham and Women’s Hospital, where he also served as Chief Medical Resident. He subsequently trained in Cardiology at Johns Hopkins University, where he was also Chief Cardiology Fellow in his final year and where he also received his MHS and PhD in Epidemiology. Dr. Ndumele’s research has been supported by multiple grants from the NIH, Robert Wood Johnson Foundation and the American Heart Association (AHA). He is Chair of the Council on Lifestyle and Cardiometabolic Health of the AHA, Past Chair of the AHA Obesity Committee, and Co-Chair of the AHA Cardiovascular-Kidney-Metabolic Health Initiative. Dr. Ndumele is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Atherosclerosis, Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), and Metabolic Syndrome.

Dr. Cingolani is an Associate Professor at The Johns Hopkins University School of Medicine, Division of Cardiology. He earned his medical degree from Universidad Nacional de La Plata, Argentina, and completed his Internship and Internal Medicine Residency at CEMIC, Buenos Aires, Argentina, and hypertension research post-doctoral fellowship at Henry Ford Hospital, Detroit, MI. After completing his Internal Medicine Residency at The Reading Hospital and Medical Center in Pennsylvania, Dr. Cingolani joined The Johns Hopkins Hospital as a Cardiology fellow, where he remained in the Faculty after his training. Currently, he is the Associate Director of The Johns Hopkins Hospital Coronary Care Unit, Director of the Hypertension Center and member of the Echocardiography Lab and Outpatient Cardiology Clinic. He also teaches pathophysiology to medical students. Dr. Cingolani’s research interests focus on hypertensive heart disease and its transition to heart failure. He aims to elucidate the mechanism/s by which certain matricellular proteins present in the heart seem to play a protective role. His research is mainly supported by the National Institute of Health (NIH). He is also the principal investigator of the DREAM study group, studying the effect of Melatonin in preventing atrial fibrillation in patients undergoing cardiac surgery. Dr. Cingolani has been recognized by the Council for High Blood Pressure Research of the American Heart Association for his work in hypertension and is the 2011 recipient of the PJ Schafer Memorial Heart Research Award, the 2012 Michel Mirowski Discovery Fund Award, and 2013 Magic that matters Fund. Dr. Cingolani is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Multifocal Atrial Tachycardia, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Cardiac Ablation, and Tissue Biopsy.

Kavita Sharma MD, is an Associate Professor of Medicine in Advanced Heart Failure/Transplant Cardiology in the Division of Cardiology at the Johns Hopkins University School of Medicine. She is the Director of the Johns Hopkins Heart Failure with Preserved Ejection Fraction Program. She sees patients at The Johns Hopkins Hospital, downtown campus. A cardiologist specializing in advanced heart failure, her clinical interests include advanced heart failure diagnosis and management, heart transplantation, and mechanical circulatory support including left ventricular assist devices. She has a specialized interest in heart failure with preserved ejection fraction (HFpEF), and directs one of the largest programs in the country dedicated to caring for patients with this condition. She is the principal investigator of numerous clinical and translational trials in HFpEF and leads a team of nurses, research coordinators, and fellows-in-training in this multi-faceted program. She is an invited speaker at national meetings in topic areas covering advanced heart failure and HFpEF. Dr. Sharma is a member of the American Heart Association, the American College of Cardiology, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. Her top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Cardiac Amyloidosis, Heart Transplant, and Fasciotomy.

Dr. Aronis is an Assistant Professor of Medicine in the Division of Cardiology at the Johns Hopkins School of Medicine, the Director of the Complex Adult Congenital Heart Disease Ablation Program, and the Associate Director of the Ventricular Tachycardia Ablation Program. He performs all types of electrophysiology procedures, with a special focus on complex catheter ablations for atrial and ventricular arrhythmias as well as complex ablations for arrhythmias in patients with adult congenital heart diseases. Dr. Aronis received his M.D. and Ph.D. degrees with Summa Cum Laude honors from the University of Patras School of Medicine in Greece. He completed his internal medicine residency training at Boston University Medical Center both his Cardiovascular Disease and Clinical Cardiac Electrophysiology fellowships at The Johns Hopkins Hospital. In addition, he has completed a post-doctoral research fellowship in Translational Research at Beth Israel Deaconess Medical Center / Harvard Medical School and an NIH funded (T-32) post-doctoral research fellowship in computational electrophysiology at the Institute of Computational Medicine at the Johns Hopkins Whiting School of Engineering. He actively engages in clinical trials and research studies aimed at improving patient outcomes and advancing the understanding of cardiac arrhythmias. He is a member of the American College of Cardiology, American Heart Association, and Heart Rhythm Society. Dr. Aronis is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Atrial Fibrillation, Ventricular Tachycardia, Arrhythmias, Cardiac Ablation, and Pacemaker Implantation.

Robert Hood is a Cardiologist in Baltimore,, Maryland. Dr. Hood is rated as an Advanced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Familial Ventricular Tachycardia, Necrosis, Mitral Valve Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Stephen Gottlieb is a Cardiologist in Baltimore,, Maryland. Dr. Gottlieb is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Heart Failure, Cardiomyopathy, Apoplexy, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Stephen Shorofsky is an Internal Medicine provider in Baltimore, Maryland. Dr. Shorofsky is rated as a Distinguished provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Arrhythmias, Ventricular Tachycardia, Paroxysmal Supraventricular Tachycardia (PSVT), Cardiac Ablation, and Pacemaker Implantation.

Timm-michael Dickfeld is a Cardiologist and a Cardiac Electrophysiologist in Baltimore, Maryland. Dr. Dickfeld is rated as a Distinguished provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Catecholaminergic Polymorphic Ventricular Tachycardia, Ventricular Tachycardia, His Bundle Tachycardia, Cardiac Ablation, and Pacemaker Implantation. Dr. Dickfeld is currently accepting new patients.

Dr. Joao Lima is a professor of medicine, radiology and epidemiology at the Johns Hopkins School of Medicine. His pioneering work in cardiac imaging using advanced MRI, CT and echocardiography has led to noninvasive techniques for predicting cardiovascular disease and calculating its extent, as well as measuring the effectiveness of modern cardiac treatments. He holds numerous patents on devices and methods for cardiac imaging and image-guided therapies. Dr. Lima graduated medical school at the University of Bahia, Brazil. He completed his cardiology fellowship at Johns Hopkins and spent two years on the faculty of the University of Pennsylvania before returning to Hopkins as a faculty member in 1992. A long-time investigator with the Multi-Ethnic Study of Atherosclerosis (MESA), Dr. Lima is credited with more than 175 articles out of that study and nearly 575 publications over his career. He is associate editor of Journal of the American College of Cardiology and serves on the editorial board of the Italian Journal of Cardiology while reviewing for other journals including the New England Journal of Medicine, Circulation and Annals of Internal Medicine. Dr. Lima has been invited to present his research throughout the Americas, Europe and Asia. Dr. Lima is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Atherosclerosis, Heart Attack, Apoplexy, Arterial Embolism, and Bone Marrow Aspiration.

Dr. David Douglass Spragg is a Professor of Medicine in the Department of Medicine (Division of Cardiology) at Johns Hopkins. In addition, he is the inaugural Edward St. John Professor of Cardiology. His research focuses on treatments for atrial fibrillation (AF), and particularly on catheter ablation for AF. Dr. Spragg received his undergraduate degree in the Comparative Study of Religion from Harvard College. He earned his medical degree from the College of Physicians and Surgeons at Columbia University. After pursuing a Sarnoff Cardiovascular research fellowship at Brigham and Women's Hospital, Dr. Spragg completed his internship and residency at Massachusetts General Hospital. He came to Johns Hopkins in 2001 for Cardiology and Cardiac EP fellowships. He served as chief fellow for the Cardiology program, and was recognized for his research during fellowship as the Michel Mirowski Cardiology Fellow. Dr. Spragg joined the faculty as an Assistant Professor in 2006, and was promoted to Associate Professor in 2014. He was promoted to the rank of Professor of Medicine in 2024. Besides his teaching and clinical appointments at the Johns Hopkins School of Medicine, Dr. Spragg is the Director of the Johns Hopkins Atrial Fibrillation Research Program. He is a Fellow of the Heart Rhythm Society. Dr. Spragg is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Atrial Fibrillation, Arrhythmias, Cardiac Tamponade, Cardiac Ablation, and Pacemaker Implantation.

Dr. Jeffrey C. Trost is an associate professor of medicine at the Johns Hopkins School of Medicine as well as director of the Cardiac Catheterization Laboratory at Johns Hopkins Bayview Medical Center. His research there focuses on cardiac disease and cardiovascular medicine. He is also currently deputy director of clinical activities at Johns Hopkins Bayview Medical Center. Dr. Trost earned his undergraduate degree at Princeton University and medical degree at the University of Pennsylvania School of Medicine. He completed a residency at the University of Texas Southwestern School of Medicine where he was chief resident from 1999-2000. He was an assistant professor of internal medicine at the University of Texas Southwestern School of Medicine and an interventional cardiovascular fellow at Brown University before joining the Johns Hopkins faculty in 2005. Dr. Trost was most recently recognized with the 2016 Hopkins Medicine Clinical Recognition Award for Quality and Safety and the 2016 Hopkins Cardiology Fellows’ Teaching Award. Dr. Trost is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery.

Dr. Marlene Stephanie Williams is an Associate professor at the Johns Hopkins University School of Medicine. Her research focuses on coronary atherosclerosis and platelet function, and her particular focus is on platelet function as it relates to the acute coronary syndrome. Dr. Williams has examined platelet function and its correlation to platelet functional genomics and runs a platelet physiology laboratory on the Johns Hopkins Bayview campus. The goal for her cardiovascular platelet laboratory has been to identify the etiology of platelet dysfunction in many disease states and apply methods that may improve this dysfunction that may eventually be translated to therapies for patients with cardiovascular disease. She is a prior recipient of an NIH career mentored award (K23) examining platelet functional genomics and an NIH RO1 award addressing platelet serotonin signaling in depression and heart disease. Dr. Williams has several publications covering platelet functional changes in settings of interventional cardiology, acute coronary syndrome, and heart disease and depression. She has participated in several NHLBI advisory committees, review groups, and study sections. Dr. Williams has been the Course Director, of the advanced clinical clerkship in coronary intensive care at the Bayview Medical center and has mentored many medical residents and cardiology fellows. Dr. Williams received her undergraduate degree in biochemistry from McGill University. She earned a medical degree from the Columbia University College of Physicians & Surgeons and completed a residency at Johns Hopkins Hospital. After completing a residency, Dr. Williams was a cardiology fellow at Mount Sinai Hospital and Johns Hopkins Hospital. Dr. Williams is currently the Clinical Director of Cardiology at Johns Hopkins Bayview Medical Center. Dr. Williams is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. Her top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Pacemaker Implantation, and Hip Replacement.

Dr. Harry A. Silber is an associate professor of medicine at the Johns Hopkins University School of Medicine. His clinical work specializes in cardiac disease and his research focuses on vascular function by MRI and non-invasive assessment of cardiac filling pressure. Dr. Silber received a doctorate in biomedical engineering as well as a medical degree from Tulane University. He completed a residency at the Hospital of the University of Pennsylvania before being selected for a fellowship in cardiology at Johns Hopkins Hospital. He joined the Johns Hopkins faculty in 2000. Dr. Silber has published extensively and holds several patents for his research for cardiovascular disease. Dr. Silber is rated as an Experienced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Apoplexy, Heart Attack, Heart Failure, and Arterial Embolism.

Frederick Kuhn is a Cardiologist in Baltimore,, Maryland. Dr. Kuhn is rated as an Advanced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Coronary Heart Disease, Arrhythmias, Catecholaminergic Polymorphic Ventricular Tachycardia, and Ventricular Tachycardia.

Russell Hillsley is a Cardiologist in Baltimore, Maryland. Dr. Hillsley is rated as an Advanced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Sick Sinus Syndrome, Arrhythmias, Familial Progressive Cardiac Conduction Defect, Pacemaker Implantation, and Cardiac Ablation.

Vikas Kalra is a Cardiac Electrophysiologist and a Cardiologist in Towson, Maryland. Dr. Kalra is rated as an Advanced provider by MediFind in the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia. His top areas of expertise are Atrial Fibrillation, Familial Ventricular Tachycardia, Ventricular Tachycardia, Pacemaker Implantation, and Cardiac Ablation. Dr. Kalra is currently accepting new patients.